Nina Bauer, Ph.D., Global Head of Commercial  Oct. 12 | 9:00am | Oxford Biomedica Ballroom  Burlington, MA  (OTCMKTS: MKKGY)  In-person Presentation  MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany.  From solving your unique upstream and downstream challenges, to meeting urgent manufacturing timelines, and navigating uncertain regulatory...

Patricio Sepulveda, Ph.D., CEO  Oct. 11 | 4:45pm | Oxford Biomedica Ballroom Towson, MD (Private)  In-person Presentation  Amplo Biotechnology is a late preclinical stage company developing AAV therapies to treat diseases of the neuromuscular junction, the connection between muscle and nerve.  Amplo’s lead asset, AMP-101, uses a muscle specific AAV...

Peter Francis, CSO/CMO  Oct. 12 | 1:15pm | Oxford Biomedica Ballroom  San Francisco, CA  (Private)  In-person Presentation  Ray Therapeutics is a late-stage preclinical biotechnology company pioneering next generation optogenetic therapies for vision restoration to individuals with blindness. The company is based in the San Francisco Bay Area. Ray Therapeutics recently received...

Brian Culley, CEO  Oct. 12 | 2:15pm | UBC Ballroom  Carlsbad, CA  (NASDAQ: LCTX)  In-person Presentation  Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Lineage develops and...

Patrick Lucy, President and CEO Oct. 11 | 5:45pm | Oxford Biomedica Ballroom   Hopkinton, MA  (Private)  In-person Presentation  Lykan Bioscience is an innovative contract development and manufacturing services organization (CDMO) focused on cell-based therapies. With decades of biopharmaceutical industry experience, Lykan offers a full range of development and manufacturing services. The...

Julia Tarasenko, SVP, Global Commercial Operation, Sales, and Pricing  Oct. 12 | 10:00am | Oxford Biomedica Ballroom  Durham, NC  (Private)  In-person Presentation  Marken is a wholly owned subsidiary of UPS and is a critical part of UPS Healthcare. With Polar Speed and Marken included, the UPS Healthcare division staffs 128 locations...

Jeff Vassallo, Senior Director, Clinical Operations Oct. 12 | 5:00pm | Oxford Biomedica Ballroom   Cincinnati, OH  (NASDAQ: MEDP)  In-person Presentation  Medpace is a scientifically-driven, global, full service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate...

Anna Wijatyk, M.D., Chief Medical Officer Oct. 12 | 2:30pm | Oxford Biomedica Ballroom   Waltham, MA  (Private)  In-person Presentation  Miltenyi Biomedicine is a newly established biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bringing cancer treatments and regenerative therapies to patients worldwide.  www.miltenyibiomedicine.com ...

Jeff Ross, Ph.D., CEO  Oct. 12 | 3:30pm | Oxford Biomedica Ballroom  Eden Prairie, MN  (NASDAQ: MIRO)  In-person Presentation  Miromatrix is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The company has developed a proprietary perfusion technology platform...

Kristi Jones, Pharm.D., CEO Oct. 11 | 5:00pm | Oxford Biomedica Ballroom   Gaithersburg, MD  (NASDAQ: NEXI)  In-person Presentation  NexImmune is a rapidly growing leader in the emerging field of antigen-directed immunotherapies. We are developing a novel technology that uses natural biology to orchestrate a targeted cell-mediated immune response across a broad...

By using this website you agree to accept our Privacy Policy and Terms & Conditions